Skip to main content
. 2023 Nov 28;20(11):806–815. doi: 10.20892/j.issn.2095-3941.2023.0313

Figure 4.

Figure 4

UCOMs have been validated in four types of cancer in large-scale clinical studies. A. Performance of HIST1H4F, a UCOM, in lung cancer detection of 508 samples. B. Performance of PCDHGB7, a UCOM, in cervical cancer detection of 844 samples. C. Performance of PCDHGB7, a UCOM, in endometrial cancer detection of 577 endometrial Pap and Tao brush samples. D. Performance of SIX6, a UCOM, in urothelial cancer detection of 177 samples.